FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures-Reference-Cited by-同舟云学术

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

Published:2016-05-20 Issue:33 Volume:7 Page:52940-52956
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wong Kah Keng¹,Gascoyne Duncan M.²,Soilleux Elizabeth J.²,Lyne Linden²,Spearman Hayley²,Roncador Giovanna³,Pedersen Lars M.⁴,Møller Michael B.⁵,Green Tina M.⁵,Banham Alison H.²

Affiliation:

1. Department of Immunology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

2. NDCLS, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

3. Monoclonal Antibody Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain

4. Department of Haematology, Roskilde Hospital, Roskilde, Denmark

5. Department of Pathology, Odense University Hospital, Odense, Denmark

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiomics data analysis identifies TM4SF4 as a cell surface target in hepatocellular carcinoma;2024-07-03

2. Integrated transcriptomics and proteomics data analysis identifies CDH17 as a key cell surface target in colorectal cancer;Computational Biology and Chemistry;2023-08

3. Silencing FOXP2 reverses vemurafenib resistance in BRAFV600E mutant papillary thyroid cancer and melanoma cells;Endocrine;2022-11-04

4. MiR-132-3p inhibits proliferation, invasion and migration of colorectal cancer cells via down-regulating FOXP2 expression;Acta Biochimica Polonica;2022-06-06

5. FOXP2 regulates thyroid cancer cell proliferation and apoptosis via transcriptional activation of RPS6KA6;Experimental and Therapeutic Medicine;2022-05-09